PT1109806E - Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas - Google Patents

Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas

Info

Publication number
PT1109806E
PT1109806E PT00940418T PT00940418T PT1109806E PT 1109806 E PT1109806 E PT 1109806E PT 00940418 T PT00940418 T PT 00940418T PT 00940418 T PT00940418 T PT 00940418T PT 1109806 E PT1109806 E PT 1109806E
Authority
PT
Portugal
Prior art keywords
paroxetine
complexes
cycllodextrins
cyclodextrines
derivatives
Prior art date
Application number
PT00940418T
Other languages
English (en)
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI001459A external-priority patent/ITMI991459A1/it
Priority claimed from IT99MI002406 external-priority patent/IT1314232B1/it
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of PT1109806E publication Critical patent/PT1109806E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT00940418T 1999-07-01 2000-06-30 Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas PT1109806E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001459A ITMI991459A1 (it) 1999-07-01 1999-07-01 Complessi di sali di paroxetina con ciclodestrine
IT99MI002406 IT1314232B1 (it) 1999-11-17 1999-11-17 Complessi di paroxetina base con ciclodestrine o derivati delleciclodestrine.

Publications (1)

Publication Number Publication Date
PT1109806E true PT1109806E (pt) 2004-02-27

Family

ID=26331667

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00940418T PT1109806E (pt) 1999-07-01 2000-06-30 Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas

Country Status (13)

Country Link
US (1) US6984632B1 (pt)
EP (1) EP1109806B8 (pt)
JP (1) JP2003503493A (pt)
KR (1) KR100759159B1 (pt)
AT (1) ATE248165T1 (pt)
AU (1) AU5535900A (pt)
BR (1) BR0006838A (pt)
CA (1) CA2341984A1 (pt)
DE (1) DE60004768T2 (pt)
DK (1) DK1109806T3 (pt)
ES (1) ES2206254T3 (pt)
PT (1) PT1109806E (pt)
WO (1) WO2001002393A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US7658913B2 (en) 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
PT3354267T (pt) * 2007-01-23 2019-09-10 Pharmagra Labs Inc Sulforafano estabilizado

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
CA2206592A1 (en) 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
US5672612A (en) 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
JP2001503406A (ja) * 1996-10-28 2001-03-13 ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ 医薬組成物
JPH10167958A (ja) * 1996-12-09 1998-06-23 Sankyo Co Ltd ロキソプロフェンナトリウム類を含有する口腔内速溶性製剤及びその製造方法
JPH10194996A (ja) * 1996-12-25 1998-07-28 Janssen Pharmaceut Nv アシル化シクロデキストリン含有製薬組成物
NZ336587A (en) 1997-01-15 2001-01-26 Smithkline Beecham P Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran
WO1998037884A1 (en) * 1997-02-27 1998-09-03 Novo Nordisk A/S Inclusion complexes in aqueous solution
HUP9700632A3 (en) * 1997-03-24 1999-10-28 Cyclolab Ciklodextrin Kutato F Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
GB9724544D0 (en) 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
EP1102764A1 (en) * 1998-08-08 2001-05-30 Smithkline Beecham Plc Paroxetine salts

Also Published As

Publication number Publication date
EP1109806A1 (en) 2001-06-27
ES2206254T3 (es) 2004-05-16
BR0006838A (pt) 2001-08-07
CA2341984A1 (en) 2001-01-11
AU5535900A (en) 2001-01-22
DE60004768D1 (de) 2003-10-02
DE60004768T2 (de) 2004-07-08
WO2001002393A1 (en) 2001-01-11
KR20010072880A (ko) 2001-07-31
JP2003503493A (ja) 2003-01-28
ATE248165T1 (de) 2003-09-15
DK1109806T3 (da) 2003-12-22
US6984632B1 (en) 2006-01-10
EP1109806B1 (en) 2003-08-27
KR100759159B1 (ko) 2007-09-14
EP1109806B8 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
HUP0101564A2 (hu) Epotilon készítmények
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
ATE223236T1 (de) Thyroxine/zyklodextrinkomplexe und ihre pharmazeutische formulierung
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
DE60045528D1 (de) Pharmazeutische zusammensetzungen, die ccr5-antagonisierende piperazinderivate enthalten
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
TR199800027T1 (xx) Difenilmetilen piperidin t�revleri.
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
PT992509E (pt) Novos derivados macrolidos
GEP20094697B (en) Condensed purine derivatives as a1 adenosine receptor antagonists
GEP20053617B (en) Bridged Piperazine Derivatives
BR0215848A (pt) Complexos de inclusão de butilfitalida com ciclodextrina ou seus derivados, processo para preparação destes e uso dos mesmos
EA200300406A1 (ru) Фармацевтическая композиция дронедарона для парентерального введения
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
FR2792529B1 (fr) Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
PT1109806E (pt) Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
AU2408602A (en) Indole derivatives and use thereof in medicines
ATE299027T1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
BR9914125A (pt) Composições farmacêuticas baseadas em alfa-ciclodextrina para administração oral de análogos lh-rh
AU1584800A (en) Immuno-active, anti-cancer and pharmacologically active polysaccharide compoundsand pharmaceutical compositions containing the polysaccharide compounds
ATE252598T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
FR2789078B3 (fr) Derives d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant